Date: 22-Aug-2019

Pfizer invests $500 million in expanding gene therapy facility

Carl O Donnell Pfizer Inc is investing $500 million to expand a manufacturing facility in Sanford, North Carolina, that plays a central role in its efforts to become a major player in gene therapy, the company said on Wednesday. The investment will add additional capacity and capabilities to a facility that makes some of Pfizers most closely watched experimental treatments. The Sanford plant manufactures therapies used for the companys late-stage experimental treatments for Duchenne Muscular Dystrophy (DMD) and hemophilia B therapies, among other gene therapies